ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

$0.84
-0.04 (-4.30%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,216.3% upside
Low Target $6.75
Average Target $11.07
High Target $12.78
Current Price $0.84
Current
$0.84
Target
$11.07
$6.75 $11.07 avg $12.78
Scenario Analysis
Bear Case
$6.75
702.6%
Low target
Base Case
$11.07
+1,216.3%
Avg target
Bull Case
$12.78
+1,419.6%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$1.39
-39.3% from high
52-Week Low
$0.50
+68.2% from low
Target vs 52W High
$11.07
+699.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%